Here is a copy of the post by 4kids yesterday. I found it

New Post Public Reply Private Reply Replies (0) Message Board
petemantx
623
Here is a copy of the post by 4kids yesterday. I found it on another site.
This is partial explanation of why she feels NR is "upside down", "stuck" in IPIX and why we could see something of the giant spike that was evidenced in AMRN where NR was also stuck. She has said in the past that IPIX runup by NR could even be more dramatic than AMRN. That awaits to be seen, but nice knowing our favorite slime are in deep trouble and that it could possibly lead to a major spike in IPIX

IPIX .. PART 1

news out of mgmt on Monday imo couldn't have been better timed

since NRs' handoff (PRO to CON) .. after 2 years and a few months working IPIX's (CTIX) $cycles of money (9.2012-12.2014) ..
in early Jan 2015 .. NR (non retail) has relentlessly brutalized IP shareholders in an attempt to get IPIX *shares*
there is a reason for that ..

a few times per year .. aware mgmts of OTC targets .. have a prime opportunity to exploit those who exploit by rote
imo this is one of those perfect times for Innovation Pharma's mgmt (IP) to exploit NRs' efforts .. specifically
against those efforts underway by NR in September 2018

some might recall the way Non Retail (NR) works ..
NR *resets* 52 week highs and 52 week lows to work off of going forward

usually the easiest way for an UPSIDE DOWN NR to *work* is to take the OTC targets' current 52 week high
and cut it in half .. and then again .. and if able to .. yet again .. and so it goes .. this can be done every year ..
every 6 months .. every Q or every week as NR can engender it

the goal is two-fold .. impact mgmt's ability to execute via a constantly reduced PPS
and triggering retails' emotions by racking up *paper losses* .. over weeks/months/years .. as an inducement to sell

when the above is aligned with NRs' 24/7 FUD .. even the most stalwart believer might be forgiven for being *impacted*

now to be clear .. most OTC targets do not outlast .. let alone survive .. NRs' unrelenting efforts to kill off the company
via a brutalized stock

almost always .. if an OTC target *outlasts* .. it usually does so with a blown out I/O (issued/outstanding)
which to be clear (and NR always likes to muddy this up) .. the I/O is not what is freely traded ..
what is freely traded is the Float (retail investors tend not to trade .. which makes their shares in the Float
closer to being restricted rather than traded) .. another *issue* NR has with IPIX

(i will go more into this aspect in my Part 2 post)

the problem NR has is when actual investors refuse to be separated from their *shares* .. and because NR
almost always forces out retail traders (not trading crews who like NR also orchestrate OTC targets' PPS by rote)
when NR relentlessly compresses an OTC targets' PPS .. NR finds themselves UPSIDE DOWN on an OTC target
that NR had previously (and successfully) worked $cycles of money on ..

those $cycles of money .. worked by NR .. can run 3 weeks .. 3 months .. 3 years

quite the dilemma facing NR re: IPIX .. specifically over NRs' *efforts* in the back half of 2018


so IPIX's previous 52 week high of $1.17 (divided by 2 = .5850)

IPIX 52-Week High
12/06/2017 1.17

was reset (and held in the 60c to mid 60c range for about 8 weeks in mid 2018)

IPIX 52-Week High
07/02/2018 0.64

before the *events and efforts* of September 2018 got underway and that *reset* on 9.7.18

IPIX 52-Week High
09/07/2018 0.5805 .. close enough to 5850c



some also might recall the *totally bogus* volume injection by NR (and by rote pawned off onto IP mgmt)

of course the reality is that mgmt did not dilute the 54,830,246 injected by NR in the last 4 months of 2018
(as comp'd to the 33,969,148 *traded* on IPIX in the first 8 months of 2018) .. IP's mgmt actually diluted
13M~ and change during the last 4 months of 2018 .. it was the usual orchestrated EOY *set up* by Non Retail
against IP investors .. because of course IPIX has been a target for years .. and NR has been UPSIDE DOWN on IPIX for years

so on 9.12.18 .. NR injects *volume* into IPIX .. and days before .. NR reset the 52 week high from 60c to 5805
on 9.7.18 .. this impacts YOY %s .. and to be clear .. those YOY %s on IPIX are *negative* .. 12 months ago
those -YOY %s were held @ mid - 40% .. that would morph to mid -80% (see below)

NR gets retail to sell by one of 3 ways .. stall a targeted PPS long enough (that was done about 2 years back)
relentlessly compress a PPS .. as has been done essentially since the *hand off* of late 2014 into 2015
or work a targeted PPS upward .. as was done *recently* (May 2019) .. which allowed NR to let some helium
out of IPIX's balloon .. otherwise NR would have been looking at a *take up* they quite possibly couldn't control
(imo 70c range ironically where NRs' cycle of money kicked off in Sept 2012 and where NR *stalled* IPIX
for months while working off prior efforts) .. and *volume* of at least 10M+ ..

on an OTC target that both outlasts and survives NRs' efforts .. it's all about NRs' *CONtroll*
and NRs' ability to *reset* the price point on their terms

this works .. until it doesn't

IPIX Historical .. September - December 2018 .. split into 4 months ..
PPS high denoted in green .. PPS low denoted in red
*volume* high denoted in red .. *volume* low denoted in green
Wash trading done by Non Retail is beyond blatant imo ..
but it's the OTC which makes it fungible to those tasked with *transparency*

so to point out the highs and lows for the last 4 months of 2018

5805c (9.7.18 reset) goes to 305c (10.5.18) goes to 21c (11.5.18) goes to 17c (12.17.18)

and

1895c (9.28.18) goes to 12c (10.19.18) goes to 1025c (11.20.18) goes to 7c (12.31.18)


12/31/2018 0.08 0.1 0.07 0.0954 631,343 .. 52 week low reset to 7c
12/28/2018 0.083 0.109 0.083 0.1036 531,169
12/27/2018 0.082 0.09 0.081 0.0876 468,153
12/26/2018 0.08 0.095 0.08 0.09 346,379
12/24/2018 0.095 0.095 0.08 0.08 372,923
12/21/2018 0.099 0.105 0.075 0.095 844,903
12/20/2018 0.11 0.11 0.0961 0.097 806,466
12/19/2018 0.12 0.12 0.103 0.11 1,060,552
12/18/2018 0.12 0.14 0.1101 0.1153 830,184
12/17/2018 0.17 0.17 0.125 0.1293 768,696
12/14/2018 0.123 0.16 0.115 0.145 414,408
12/13/2018 0.155 0.155 0.116 0.1202 459,830
12/12/2018 0.125 0.13 0.1152 0.127 523,824
12/11/2018 0.14 0.16 0.125 0.1399 849,983
12/10/2018 0.1299 0.16 0.1299 0.16 226,349
12/07/2018 0.123 0.135 0.11 0.133 295,802
12/06/2018 0.1245 0.1412 0.122 0.13 321,739
12/04/2018 0.12 0.1369 0.12 0.1231 420,537
12/03/2018 0.13 0.14 0.121 0.1343 345,949

11/30/2018 0.1375 0.1375 0.128 0.135 497,326
11/29/2018 0.1301 0.15 0.125 0.1327 1,379,661
11/28/2018 0.1325 0.15 0.1288 0.133 875,275
11/27/2018 0.125 0.1325 0.1101 0.132 475,115
11/26/2018 0.17 0.17 0.12 0.126 485,796
11/23/2018 0.1135 0.149 0.1135 0.14 884,102
11/21/2018 0.108 0.115 0.103 0.11 462,656
11/20/2018 0.108 0.115 0.1025 0.11 392,564
11/19/2018 0.122 0.132 0.105 0.11 1,058,420
11/16/2018 0.1369 0.1369 0.113 0.122 493,784
11/15/2018 0.125 0.137 0.115 0.137 687,206
11/14/2018 0.14 0.14 0.125 0.128 286,871
11/13/2018 0.17 0.17 0.1335 0.14 274,668
11/12/2018 0.155 0.155 0.135 0.14 690,455
11/09/2018 0.16 0.175 0.145 0.152 486,370
11/08/2018 0.14 0.175 0.137 0.1645 1,470,273
11/07/2018 0.1661 0.172 0.14 0.15 811,782
11/06/2018 0.18 0.185 0.159 0.1679 463,864
11/05/2018 0.19 0.21 0.17 0.185 1,033,642
11/02/2018 0.13 0.189 0.128 0.187 1,372,537
11/01/2018 0.135 0.14 0.125 0.13 634,420

10/31/2018 0.135 0.135 0.127 0.133 386,639
10/30/2018 0.13 0.14 0.1254 0.132 337,278
10/29/2018 0.134 0.144 0.13 0.135 1,114,409 .. note 9.13.18
10/26/2018 0.138 0.14 0.123 0.136 876,765
10/25/2018 0.1415 0.15 0.131 0.1374 619,964
10/24/2018 0.138 0.148 0.128 0.148 847,006
10/23/2018 0.138 0.14 0.122 0.137 774,467
10/22/2018 0.18 0.18 0.125 0.132 951,411 .. note 9.20.18
10/19/2018 0.1635 0.164 0.12 0.1462 1,869,230
10/18/2018 0.1779 0.1779 0.1534 0.164 788,072
10/17/2018 0.18 0.18 0.165 0.1779 446,377
10/16/2018 0.19 0.2 0.177 0.18 875,248
10/15/2018 0.2 0.24 0.18 0.1856 660,059
10/12/2018 0.19 0.205 0.177 0.2 713,829
10/11/2018 0.16 0.1896 0.159 0.1896 1,575,415
10/10/2018 0.1991 0.2 0.16 0.1626 1,547,811
10/09/2018 0.238 0.27 0.175 0.1841 2,131,163
10/08/2018 0.24 0.2499 0.22 0.238 205,005
10/05/2018 0.253 0.305 0.233 0.24 287,390
10/04/2018 0.29 0.29 0.24 0.253 200,849
10/03/2018 0.25 0.295 0.24 0.28 285,431
10/02/2018 0.1975 0.256 0.19 0.25 285,150
10/01/2018 0.21 0.21 0.18 0.1957 715,877

09/28/2018 0.264 0.264 0.1895 0.202 1,420,473
09/27/2018 0.27 0.273 0.242 0.2649 737,406
09/26/2018 0.308 0.308 0.26 0.2782 361,590
09/25/2018 0.2965 0.3136 0.27 0.2993 302,231
09/24/2018 0.299 0.31 0.28 0.2955 236,198
09/21/2018 0.299 0.299 0.272 0.299 250,475
09/20/2018 0.2486 0.33 0.2358 0.299 924,370
09/19/2018 0.233 0.25 0.21 0.2486 1,015,394
09/18/2018 0.263 0.269 0.208 0.233 886,593
09/17/2018 0.285 0.293 0.251 0.27 533,946
09/14/2018 0.29 0.295 0.262 0.29 753,114
09/13/2018 0.339 0.346 0.2271 0.29 1,109,738
09/12/2018 0.4 0.4 0.3 0.33 1,016,307 .. NRs' volume injection gets underway
09/11/2018 0.425 0.47 0.425 0.452 86,434
09/10/2018 0.38 0.5303 0.38 0.435 139,753
09/07/2018 0.39 0.5805 0.371 0.565 274,968 .. 52 week high reset from July 2018's 60c to 5805c
09/06/2018 0.38 0.4 0.37 0.4 194,838
09/05/2018 0.39 0.4025 0.3625 0.378 189,130
09/04/2018 0.398 0.41 0.3871 0.3935 166,467




now IPIX -YOY %s .. pulled monthly from early July 2018 to early 2019 .. note the pattern in play
this is SOP when a target is relentlessly compressed PPS wise for years ..


IPIX .. 7.2.18
Price Performance (Last 52 Weeks)
06/29/2018 -37.89%

IPIX .. 8.2.18
PRICE PERFORMANCE (LAST 52 WEEKS)
08/01/2018 -47.02%

IPIX .. 9.4.18
Price Performance (Last 52 Weeks)
09/04/2018 -47.18%

IPIX .. 10.3.18
Price Performance (Last 52 Weeks)
10/02/2018 -65.01%

IPIX .. 11.2.18
Price Performance (Last 52 Weeks)
11/01/2018 -82.55%

IPIX .. 12.4.18
Price Performance (Last 52 Weeks)
12/03/2018 -83.00%

IPIX .. 1.3.19
Price Performance (Last 52 Weeks)
01/02/2019 -84.88%



now here's what happened back in May when NR *manipulated* IPIX upward on *volume* ..


IPIX 5.3.19 (NRs' test to 19c stopped out @ approx 11AM .. hot knife thru butter) closed @ 171c
Price Performance (Last 52 Weeks)
05/02/2019 -62.95%

Volume 403,294
Volume (10 day Average) 366,852
Volume (90 day Average) 419,712

IPIX .. 5.6.19 .. closed @ 2205c
Price Performance (Last 52 Weeks)
05/03/2019 -59.38%

Volume 760,633
Volume (10 day Average) 390,843
Volume (90 day Average) 414,805

IPIX 5.8.19 .. closed @ 345c
Price Performance (Last 52 Weeks)
05/07/2019 +9.74% .. CANT have that ..

Volume 2,366,980 ** that 2.3M *volume* gets around ..
Volume (10 day Average) 642,244
Volume (90 day Average) 443,198

IPIX 5.10.19 .. closed @ 215c
Price Performance (Last 52 Weeks)
05/09/2019 -19.34%

Volume 2,377,415 .. see 5.8.19's *volume* (and 7.22.19's *volume*)
Volume (10 day Average) 831,474
Volume (90 day Average) 467,984

IPIX 5.13.19 .. closed @ 176c .. round robin reset done by NR in 6 *trading* days .. SOS DD
Price Performance (Last 52 Weeks)
05/10/2019 -44.74%

Volume 668,718
Volume (10 day Average) 1,038,993
Volume (90 day Average) 487,388

IPIX 5.15.19 .. closes @ 20c
Price Performance (Last 52 Weeks)
05/14/2019 -54.82%

Volume 237,776
Volume (10 day Average) 1,133,260
Volume (90 day Average) 492,137

IPIX 5.17.19 .. closes @ 25c (reminder helium release done to negate news out 5.16.19)
Price Performance (Last 52 Weeks)
05/16/2019 -45.76%

Volume 2,651,634
Volume (10 day Average) 1,548,678
Volume (90 day Average) 535,925



which brings me to this past week .. reminder .. IP's mgmt released exactly 5 PRs since 5.16.19
while all are important .. 3 are significant *imo* ..

5.16.19
INNOVATION PHARMACEUTICALS ANNOUNCES NON-BINDING TERM SHEET SIGNED WITH GLOBAL PHARMACEUTICAL COMPANY TO DEVELOP AND COMMERCIALIZE BRILACIDIN FOR ULCERATIVE PROCTITIS/PROCTOSIGMOIDITIS

6.6.19
INNOVATION PHARMACEUTICALS SIGNS AGREEMENT FOR ADVANCED ORAL TABLET TECHNOLOGY IN TREATING INFLAMMATORY BOWEL DISEASE

7.22.19
INNOVATION PHARMACEUTICALS ANNOUNCES LICENSE AGREEMENT WITH ALFASIGMA S.P.A. FOR THE DEVELOPMENT AND COMMERCIALIZATION OF BRILACIDIN IN ULCERATIVE PROCTITIS/ULCERATIVE PROCTOSIGMOIDITIS

http://www.ipharminc.com/press-release

so let's see what -YOY %s and *volume avgs* are on IPIX for the 2 weeks in July 2019 surrounding the AS PR


IPIX 7.15.19 .. closes @ 1799c
Price Performance (Last 52 Weeks)
07/12/2019 -64.42%

Volume 181,236
Volume (10 day Average) 234,147
Volume (90 day Average) 514,827

IPIX 7.17.19 .. closes @ 15c
Price Performance (Last 52 Weeks)
07/16/2019 -72.67%

Volume 460,061
Volume (10 day Average) 228,371
Volume (90 day Average) 512,870

IPIX 7.19.19 .. closes @ 12353c .. 5 digit hidden (per usual NRs' gyrations do their best to *offset* 7.22.19's news)
Price Performance (Last 52 Weeks)
07/18/2019 -75.70%

Volume 695,522
Volume (10 day Average) 266,831
Volume (90 day Average) 516,975

IPIX 7.22.19 .. closes @ 18c
Price Performance (Last 52 Weeks)
07/19/2019 -78.33%

Volume 2,347,575 .. there's that 2.3M *volume* again ..
Volume (10 day Average) 322,582
Volume (90 day Average) 521,605


IPIX .. 7.24.19 .. closes @ 16c
Price Performance (Last 52 Weeks)
07/23/2019 -74.25%

Volume 1,094,320
Volume (10 day Average) 642,888
Volume (90 day Average) 554,004

IPIX 7.26.19 .. closes @ 17668c .. 5 digit hidden
Price Performance (Last 52 Weeks)
07/25/2019 -70.65%

Volume 303,012
Volume (10 day Average) 736,620
Volume (90 day Average) 563,001



so in a nutshell .. NR is stuck .. they have a few options .. as the clock ticks forward to -YOY %s decreasing
as Fall 2019 comes into view .. NR can *stall* .. imo what they have done for the last two days on IPIX .. a tightly
held PPS range that is wash traded incrementally upward (i refer to this as laddering) on *low volume* ..


07/26/2019 0.16 0.1767 0.155 0.1767 303,012
07/25/2019 0.174 0.174 0.155 0.1615 359,879



of course that *effort* only works so long for NR .. news out of *aware* OTC mgmt/s can come at any time
(imo the sequence is more telling sometimes than the news)

or NR can do another helium release on IPIX (as they did starting back on 5.3.19) .. anyone actually *observing*
that effort would have seen that NR almost lost control of IPIX a few times for that round .. so that is a potential
roll of the dice for an entity used to *controlling* outcomes

this tho' imo may have some appeal .. because NR needs to make IPIX a *trading* stock again (as it was for both
retail traders and NRs' efforts from 9.2012 to 12.2014 .. ($cycles of money) .. some might
remember the volume avgs NR worked on IPIX (CTIX) before the hand off .. to say nothing of the PPS *then*
.. keeping it simple .. avg volume 500000 x $3.00 (PPS) .. brings *daily* .. er .. trading volume dollar amount
to $1,500,000.00 .. that $1,500,000.00 gets revealing with today's IPIX PPS (and a reminder that NR can
manipulate IPIX's 10 day avg far more easily than the 90 day volume avg) .. so using a PPS of 20c (rounded up for the example)

IPIX would be trading 7,500,000 *shares* daily .. NR CANT and they don't .. at least not yet

of course most OTC targets don't *outlast* let alone *survive* NRs' efforts ..

IPIX did *record* volume with the release of 5.16.19's PR out of IP
(of course it was wash traded in advance earlier that month) .. which again highlights NRs' *dilemma*


05/17/2019 0.355 0.36 0.244 0.25 2,651,634
05/16/2019 0.213 0.33 0.21 0.32 4,413,783 .. record setting volume
05/15/2019 0.2 0.2099 0.19 0.2 237,776
05/14/2019 0.183 0.215 0.183 0.197 880,776
05/13/2019 0.195 0.2045 0.171 0.176 668,718
05/10/2019 0.287 0.32 0.2039 0.21 2,377,716
05/09/2019 0.3515 0.3558 0.284 0.292 863,112
05/08/2019 0.435 0.4351 0.3103 0.345 2,366,980
05/07/2019 0.2352 0.423 0.2205 0.417 2,513,988
05/06/2019 0.173 0.25 0.1595 0.2205 760,633
05/03/2019 0.156 0.19 0.156 0.171 403,294



now contrast that *volume* and *effort* by NR .. with this last week's effort ..


07/26/2019 0.16 0.1767 0.155 0.1767 303,012
07/25/2019 0.174 0.174 0.155 0.1615 359,879
07/24/2019 0.15 0.175 0.15 0.16 1,094,320
07/23/2019 0.1825 0.19 0.14 0.147 1,216,961
07/22/2019 0.1395 0.24 0.1395 0.18 2,347,575 .. AS PR out



the 24c HOD on 7.22.19 is misleading .. in that only 2 trades went off @ 24c (7k/3k) @ 9:57:33AM and 9:57:36AM ..
.. the *turn/reset* NR does by rote on IPIX was underway within 28 minutes of the PR being issued (my copy rec'd @ 9:29AM)


so this is IPIX's data after Friday's (7.26.19) *efforts* .. IPIX had a close of 17668 .. note the tiny reduction on -YOY %

Price Performance (Last 52 Weeks)
07/26/2019 -67.58%
Volume 0
Volume (10 day Average) 748,261
Volume (90 day Average) 562,187



the issue of NRs' inability to part IP investors of *significance* over the years that NR brutalized IPIX
(4 years and 7 months now) remains in alignment with IP mgmt's ability to execute going forward
(as was done with this past week's news) .. that creates even more *issues* for NR .. besides the obvious of
IPIX's *volatility* and NRs' penchant for closing IPIX *down* as frequently as able to

one other aspect that some might find *revealing* .. as some may know .. (because NRs' usual refrain is
to note the market's .. er .. reaction or lack there of re: PPS .. as if the *market* blocks for 100s of 1000s of *volume*
on the ask or at bid as NR requires) .. those *actual* MMs (or ECNs) who actually do the *trade activity* (vs the
decoys who play them on RT l2) .. report to Finra each month their actual volume .. which Finra kindly breaks
down into %s .. so those with interest can note who does what .. vs who shows what daily on RT l2 (blocking or wash trading by decoys)

make no mistake .. NR isn't retail .. no one does smoke and mirrors better than NR .. but once NRs' patterns
are understood .. it effectively removes the emotional component entirely .. and reveals NRs' warts in total ..
effectively *neutralizing* Non Retails' efforts

this is IPIX's volume by month in 2019 as reported to Finra .. and the number of MMs/ECNs who reported (total)
there are only 3 MMs that matter re: IPIX .. and it's been the case for years now (CDEL/ETRF/NITE)

note in the giant shell game that NR utilizes .. CANT is now GTSM


JUN 2019 ~ 6,924,408 .. 7 .. 3 PRIMARY MMs did 89.54% of JUN 2019's volume (6,200,578)
MAY 2019 ~ 23,313,601 .. 16 .. 3 PRIMARY MMs did 77.91% of MAY 2019's volume (18,162,633)
APR 2019 ~ 8,643,366 .. 8 .. 3 PRIMARY MMs did 85.77% of APR 2019's volume (7,413,380)
MAR 2019 ~ 6,751,376 .. 11 .. 3 PRIMARY MMs did 84.94% of MAR 2019's volume (5,734,853)
FEB 2019 ~ 10,152,877 .. 11 .. 3 PRIMARY MMs did 76.96% of FEB 2019's volume (7,813,424)
JAN 2019 ~ 8,556,711 .. 10 .. 3 PRIMARY MMs did 81.93% of JAN 2019's volume (7,010,709)


Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

CSS Revamps Identity, Emphasizing Senior Living Tech

Updated Category News Views 3

CSS Takes a Bold Step with a Fresh Brand Identity Every now and then, you see a company shake off the old coat and put on a polished new one. That's what CSS is doing with its updated brand, staking its claim as a heavyweight tech player in the senior living sector. No small feat, given the challenges stacked against these aging communities—tasked with keeping...

Continue Reading
MasterBrand's 2027 Kitchen Trends: Embrace Warmth

Updated Category News Views 3

Wood Finishes and the Warm Embrace Alright folks, let's cut through the fluff and get to the heart of the matter: wood finishes are making a roaring comeback in 2027 kitchens. And it's not just some passing phase, we're talking a comprehensive shift toward warmer and more natural kitchen designs. MasterBrand, Inc. isn't just throwing darts at a board here. They surveyed a...

Continue Reading
Mutare Sharpens Security for Webex Calls with Precision

Updated Category News Views 3

Control Dialed In: Tailored Call Screening Kicking things up a notch, Mutare is redefining call security by fine-tuning their Voice Security for Webex Calling. Imagine this—custom rules now let organizations shape a security policy down to the very last detail, ensuring unwanted calls don’t slip through the cracks. Wave goodbye to the broad-strokes approach. Precision...

Continue Reading
Alcott HR's Sales Strategy Gets a Boost with New Hire

Updated Category News Views 7

Alcott HR Ramps Up Sales Firepower Now here's something fresh from the world of human resources outsourcing—Alcott HR has grabbed a new ace for their sales team. Eldin Radoncic is the name you'll want to remember, folks, because he's diving headfirst into the Director of Sales seat at this IRS Certified and ESAC Accredited player based out in good old Farmingdale, New...

Continue Reading
Lumicell Expands LumiSystem in Breast Cancer Surgery

Updated Category News Views 5

Innovation in Breast Cancer Surgery: A Real-World Game Changer? You’ve got your flashlight guiding a scared child through the dark, and in the healthcare world, Lumicell is promising to do just that for surgeons navigating the tricky maze of breast cancer surgery. Their LumiSystem is making waves in breast-conserving surgery—new kid on the block with a real chance at...

Continue Reading
Postal Connections Expands with New Hillsboro Opening

Updated Category News Views 4

Expanding Horizons in Hillsboro In the world of postal and office services, Annex Brands, Inc. is making headlines by launching yet another Postal Connections spot, this time planting its flag in the tech-centric town of Hillsboro, Oregon. Spearheaded by Jason Rautenkranz, this expansion is more than just another dot on a map—it's a strategic push into one of the...

Continue Reading
Inovonics Duress Card Enhances Safety for K-12 and Beyond

Updated Category News Views 4

A New Dawn for Safety in Schools and More It's about time we talk about something more substantial than just beefing up security cameras or tightening door locks. Real-world problems require nimble solutions, and that's where Status Solutions steps in with the Inovonics Duress Card. It's not just another gadget; it's a lightweight, wrist-mounted lifeline designed to say,...

Continue Reading
Orthopedic Expert Highlighting Midwest Pain Access Gaps

Updated Category News Views 4

Over in the vast sprawl of rolling plains and prairie winds, folks in the Upper Midwest are grappling with an ironic reality. As technological advancements blaze trails, people suffering from vertebrogenic pain are finding themselves up against a wall of limited access to specialized care. We’ve got Dr. James T. Brunz, the man of the hour, one of only about 15 Intracept...

Continue Reading
FC2 Condom Educates NYC on Health and Wellness

Updated Category News Views 8

Union Square Becomes a Hub of Interactivity The heart of NYC pulsed with purpose as FC2 Female Condom set up shop in Union Square, using the iconic location as a stage for a different kind of celebration. Clear Future, the manufacturer behind FC2, marked Global Female Condom Day with an event unlike any other. It wasn't just about the product—it was a call to educate...

Continue Reading
MSP360 Unveils Free Proxmox Backup: A Game Changer?

Updated Category News Views 6

Backing Up: New Paths for Proxmox Users Ever get that feeling of uncovering something truly worth its weight in gold? That's what MSP360 just dropped on us, with their new backup solution for Proxmox that won’t cost you a dime upfront. They're calling it the Community Edition, and it’s not only free, but it comes with all the bells and whistles for protecting those...

Continue Reading

Top 5 Most Recently Viewed Articles

The Surge in Human-Machine Interface Market Growth Forecast

Updated Category News Views 102

Overview of the Human-Machine Interface Market The global human-machine interface (HMI) market is currently valued at about USD 4.07 billion and is expected to grow significantly, possibly reaching USD 10.64 billion within the next decade. This remarkable growth reflects a compound annual growth rate (CAGR) of 10.1%. The importance of Human-Machine Interfaces stems from...

Continue Reading
Mattel, Inc. CFO Anthony DiSilvestro Sets Retirement Plans

Updated Category News Views 248

Leadership Transition at Mattel, Inc. Mattel, Inc. (NASDAQ: MAT), the recognized leader in toy production, has announced a significant transition within its executive team as its Chief Financial Officer, Anthony DiSilvestro, has plans to retire. The planned retirement is set for May, with the company actively searching for DiSilvestro's successor. The transition strategy...

Continue Reading
Exciting Progress in B-cell Lymphoma Treatments with REC-3565

Updated Category News Views 134

Groundbreaking Steps in Cancer Treatment with REC-3565 Recursion, a trailblazer in the TechBio realm, has announced an exciting new development: the first patient has been dosed in a Phase 1 clinical study of REC-3565, a selective MALT1 inhibitor aimed at treating relapsed or refractory B-cell lymphomas. This endeavor signifies a pivotal moment in the realm of...

Continue Reading
Understanding Dow Inc.'s Legal Challenges and Stock Performance

Updated Category News Views 361

Legal Challenges Faced by Dow Inc. As one of the leading companies in materials science solutions, Dow Inc. (NYSE: DOW) is currently facing significant legal challenges that are affecting its investors. The ongoing situation involves a class action lawsuit aimed at protecting shareholders who bought Dow securities between late January and late July. The legal proceedings...

Continue Reading
Palvella Therapeutics Welcomes David W. Osborne as Chief Innovator

Updated Category News Views 129

Palvella Therapeutics Appoints New Chief Innovation Officer Palvella Therapeutics, Inc. has recently announced the appointment of Dr. David W. Osborne as their Chief Innovation Officer. With over 25 years of exceptional experience in the pharmaceutical industry, Dr. Osborne brings a wealth of knowledge in developing innovative therapies for serious, rare genetic skin...

Continue Reading